Approval · Notice of Compliance 2642 · 2001
TRELSTAR: Notice of Compliance 2642
Issued March 29, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2642
- Date
- March 29, 2001
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: for the management and relief of chronic pain associated with endometriosis
- Therapeutic class
- Luteinizing hormone-releasing hormone (lhrh) analog
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRELSTAR | Not yet assigned | — |
Medicinal ingredients
- TRIPTORELIN PAMOATE 3.75 MG per VIAL